Alberto Licci

832 total citations
20 papers, 608 citations indexed

About

Alberto Licci is a scholar working on Microbiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Alberto Licci has authored 20 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Microbiology, 9 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Alberto Licci's work include Antimicrobial Peptides and Activities (13 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Biochemical and Structural Characterization (5 papers). Alberto Licci is often cited by papers focused on Antimicrobial Peptides and Activities (13 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Biochemical and Structural Characterization (5 papers). Alberto Licci collaborates with scholars based in Italy, Poland and United States. Alberto Licci's co-authors include Giorgio Scalise, Oscar Cirioni, Carmela Silvestri, Roberto Ghiselli, Vittorio Saba, Federico Mocchegiani, Fiorenza Orlando, Wojciech Kamysz, Andrea Giacometti and Jerzy Łukasiak and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Alberto Licci

20 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alberto Licci Italy	15	411	349	146	96	60	20	608
Giuseppina D’Amato Italy	17	428 1.0×	339 1.0×	173 1.2×	107 1.1×	47 0.8×	21	635
Donna M. Easton Australia	9	350 0.9×	254 0.7×	174 1.2×	41 0.4×	72 1.2×	9	574
Carlo Brouwer Netherlands	15	409 1.0×	271 0.8×	71 0.5×	101 1.1×	62 1.0×	24	717
Hilde Ulvatne Norway	11	490 1.2×	410 1.2×	124 0.8×	62 0.6×	101 1.7×	11	646
Su-Pin Koo United States	8	256 0.6×	237 0.7×	68 0.5×	158 1.6×	58 1.0×	8	505
Yael Gov Israel	13	290 0.7×	707 2.0×	47 0.3×	489 5.1×	58 1.0×	19	918
Ester Fusté Spain	13	295 0.7×	356 1.0×	59 0.4×	52 0.5×	68 1.1×	22	689
Katrina Browne Australia	7	314 0.8×	223 0.6×	44 0.3×	69 0.7×	47 0.8×	16	478
Toshihiko Agata Japan	3	120 0.3×	346 1.0×	40 0.3×	220 2.3×	83 1.4×	5	739
A Severin United States	9	183 0.4×	206 0.6×	160 1.1×	100 1.0×	133 2.2×	14	738

Countries citing papers authored by Alberto Licci

Since Specialization

Citations

This map shows the geographic impact of Alberto Licci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Licci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Licci more than expected).

Fields of papers citing papers by Alberto Licci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Licci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Licci. The network helps show where Alberto Licci may publish in the future.

Co-authorship network of co-authors of Alberto Licci

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Licci. A scholar is included among the top collaborators of Alberto Licci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Licci. Alberto Licci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barocci, Simone, et al.. (2015). Listeria monocytogenes meningitis in an immunocompromised patient.. PubMed. 38(1). 113–8. 15 indexed citations

Ghiselli, Roberto, Andrea Giacometti, Oscar Cirioni, et al.. (2007). Pretreatment With the Protegrin IB‐367 Affects Gram‐Positive Biofilm and Enhances the Therapeutic Efficacy of Linezolid in Animal Models of Central Venous Catheter Infection. Journal of Parenteral and Enteral Nutrition. 31(6). 463–468. 24 indexed citations

Barchiesi, Francesco, Oscar Cirioni, Daniela Arzeni, et al.. (2007). In-VitroActivity of the Synthetic Protegrin IB-367 Alone and in Combination with Antifungal Agents Against Clinical Isolates ofCandidaspp.. Journal of Chemotherapy. 19(5). 514–518. 9 indexed citations

Ghiselli, Roberto, Oscar Cirioni, Andrea Giacometti, et al.. (2006). THE CATHELICIDIN-DERIVED TRITRPTICIN ENHANCES THE EFFICACY OF ERTAPENEM IN EXPERIMENTAL RAT MODELS OF SEPTIC SHOCK. Shock. 26(2). 195–200. 12 indexed citations

Ghiselli, Roberto, Andrea Giacometti, Oscar Cirioni, et al.. (2006). RNAIII-INHIBITING PEPTIDE IN COMBINATION WITH THE CATHELICIDIN BMAP-28 REDUCES LETHALITY IN MOUSE MODELS OF STAPHYLOCOCCAL SEPSIS. Shock. 26(3). 296–301. 8 indexed citations

Cirioni, Oscar, Andrea Giacometti, Roberto Ghiselli, et al.. (2006). Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides. 27(9). 2104–2110. 38 indexed citations

Cirioni, Oscar, Roberto Ghiselli, Fiorenza Orlando, et al.. (2006). LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria. Antimicrobial Agents and Chemotherapy. 50(5). 1672–1679. 130 indexed citations

Cirioni, Oscar, et al.. (2006). In Vitro Activities of Tritrpticin Alone and in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 50(11). 3923–3925. 19 indexed citations

Kamysz, Wojciech, Carmela Silvestri, Oscar Cirioni, et al.. (2006). In Vitro Activities of the Lipopeptides Palmitoyl (Pal)-Lys-Lys-NH ₂ and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-Positive Cocci. Antimicrobial Agents and Chemotherapy. 51(1). 354–358. 40 indexed citations

10.

Cirioni, Oscar, Andrea Giacometti, Roberto Ghiselli, et al.. (2005). RNAIII‐Inhibiting Peptide Significantly Reduces Bacterial Load and Enhances the Effect of Antibiotics in the Treatment of Central Venous Catheter–AssociatedStaphylococcus aureusInfections. The Journal of Infectious Diseases. 193(2). 180–186. 71 indexed citations

11.

Cirioni, Oscar, Wojciech Kamysz, Giuseppina D’Amato, et al.. (2005). In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. Journal of Antimicrobial Chemotherapy. 55(2). 272–274. 25 indexed citations

12.

Cirioni, Oscar, Andrea Giacometti, Roberto Ghiselli, et al.. (2005). Temporin A Alone and in Combination with Imipenem Reduces Lethality in a Mouse Model of Staphylococcal Sepsis. The Journal of Infectious Diseases. 192(9). 1613–1620. 15 indexed citations

13.

Cirioni, Oscar, Wojciech Kamysz, Giuseppina D’Amato, et al.. (2005). In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. International Journal of Antimicrobial Agents. 26(3). 235–240. 25 indexed citations

14.

Giacometti, Andrea, Oscar Cirioni, Wojciech Kamysz, et al.. (2005). In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. Journal of Antimicrobial Chemotherapy. 56(2). 410–412. 20 indexed citations

15.

Cirioni, Oscar, Andrea Giacometti, Roberto Ghiselli, et al.. (2005). Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides. 27(6). 1210–1216. 42 indexed citations

16.

Giacometti, Andrea, Oscar Cirioni, Roberto Ghiselli, et al.. (2005). Comparative Efficacies of Quinupristin-Dalfopristin, Linezolid, Vancomycin, and Ciprofloxacin in Treatment, Using the Antibiotic-Lock Technique, of Experimental Catheter-Related Infection Due to Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49(10). 4042–4045. 43 indexed citations

17.

Cirioni, Oscar, Wojciech Kamysz, Carmela Silvestri, et al.. (2005). In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides. 26(11). 2111–2116. 22 indexed citations

18.

Cirioni, Oscar, Wojciech Kamysz, Giuseppina D’Amato, et al.. (2005). In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised Patients. Antimicrobial Agents and Chemotherapy. 49(3). 1249–1252. 28 indexed citations

19.

Cirioni, Oscar, Wojciech Kamysz, Carmela Silvestri, et al.. (2005). In Vitro Activity and Killing Effect of Uperin 3.6 against Gram-Positive Cocci Isolated from Immunocompromised Patients. Antimicrobial Agents and Chemotherapy. 49(9). 3933–3936. 9 indexed citations

20.

Cirioni, Oscar, Wojciech Kamysz, Carmela Silvestri, et al.. (2005). In Vitro Activity and Killing Effect of Citropin 1.1 against Gram-Positive Pathogens Causing Skin and Soft Tissue Infections. Antimicrobial Agents and Chemotherapy. 49(6). 2507–2509. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact